Bristol-Myers Squibb Company
$164.82B- Market cap
- $129.92B
- Debt
- +$45.11B
- Cash
- −$10.21B
Capital structure 74% equity / 26% debt · EV / Revenue 3.42x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
BMY · price snapshotP/E 18.38x
$63.60Snapshot Sep 16, 2026, 4:00 PM ET
Implied fair value · at ABBV's multiple
$384.87505.1% above market
3.46 BMY Annual EPS×111.23x ABBV P/E=$384.87
Market $63.60Implied $384.87
ABBV · price snapshotP/E 111.23x
$262.51Snapshot Sep 16, 2026, 4:00 PM ET
Implied fair value · at BMY's multiple
$43.3883.5% below market
2.36 ABBV Annual EPS×18.38x BMY P/E=$43.38
Market $262.51Implied $43.38